Feedback / Questions
AVS100 - Avstera
https://www.prnewswire.com/news-releases/avstera-therapeutics-receives-fda-orphan-drug-designation-on-avs100-for-treatment-of-advanced-stage-melanoma-301675784.html
Nov 11, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next